IVF Converted to IUI: When a Stimulation Cycle May Change Course

IVF stimulation is designed to encourage several follicles to grow so eggs can be collected and fertilised in a laboratory. Occasionally the response is lower than predicted. Continuing to retrieval may still be reasonable when obtaining even one egg has meaningful value; in other cases a team may recommend cancellation or consider IUI. The number of visible follicles is not identical to the number of eggs ultimately obtained. A transparent conversation should address this uncertainty before anyone agrees to a changed pathway.

IUI relies on sperm reaching an egg inside the reproductive tract. Someone with bilateral tubal blockage, a reason to avoid intercourse, or severe sperm limitations may not benefit from simply switching away from IVF. The doctor needs the tubal assessment, semen results, ovulation history and current scan measurements. Patients having IVF for genetic testing also cannot achieve that objective through IUI. Conversion is a clinical option for a narrow group, not a rescue tactic for every disappointing scan.

Ask to review the ultrasound findings alongside hormone results when these are part of the protocol. Follicles of different sizes may mature at different times; an early scan does not always represent the final response. Estradiol trends can add context but cannot guarantee how many eggs are present. A clinician might continue stimulation, reassess, or make a same-day decision depending on the treatment plan. Do not independently alter doses based on internet follicle-size charts.

HomeIVF is a doctor-led, home-supported fertility-care model intended to avoid unnecessary clinic appointments without compromising medical supervision. In the context of IVF converted to IUI, an appropriately offered teleconsultation can help organise reports and decisions; selected blood collection or injection support might be possible when the treating doctor prescribes it and the service is verifiably available. Ask who checks results, who signs medication changes and what should happen if monitoring contradicts the original plan. An at-home appointment cannot substitute for a necessary pelvic or follicular ultrasound. Egg retrieval, sperm procedures when invasive, embryology, freezing and embryo transfer require an appropriately equipped facility. The useful question is whether each contact produces a clinical decision, not whether it happens through a phone or a clinic desk.

A conversion does not make drug exposure disappear. Multiple growing follicles can increase the risk of multiple pregnancy if an IUI or intercourse cycle proceeds. Conversely, a small number of follicles does not remove every risk. Your specialist must consider whether proceeding is safe, which trigger is appropriate, and whether abstaining from intercourse is advised when a cycle is cancelled for safety. Do not assume that medication already purchased obliges you to continue.

The realistic options are often retrieval as planned, changing to IUI when appropriate, or stopping the cycle and reviewing the protocol. Compare expected usefulness rather than only immediate cost. Retrieval may provide embryology information but involves a facility procedure and laboratory expense. IUI avoids egg collection but offers less control over fertilisation. Cancellation can protect safety or allow a more informed next attempt. None of the three guarantees pregnancy or means the preceding treatment was wasted.

For this topic, do not approve treatment solely because a single report mentions IVF converted to IUI. Clinical context may change the appropriate option, and a useful explanation should separate established findings from assumptions. Ask the clinician to discuss likely benefits, limits, important alternatives and the possibility that no pregnancy results. The purpose of informed consent is to understand a medical choice, not simply to sign a form before payment. The quote should distinguish consultation, necessary diagnostic work, medication, monitoring, facility procedures, laboratory services and any ongoing storage or later transfer. Ask what is payable if the plan changes or treatment is cancelled; price comparisons without those details can be misleading. If an unexpected finding changes treatment, request an updated document that states the new action, medicine schedule, timing and reason. Patients should not have to infer a dose change from an informal chat.

Before signing amended consent, request a written account of charges already incurred, medicines still required, whether unused services will be credited, and the separate IUI fee. The original IVF quote may include laboratory work that will not take place. Conversely, repeated scans or new medicines may add cost. Confirm the final medication instructions in writing and ask who will answer urgent questions outside the normal consultation. Treatment changes should never be explained only as an invoice adjustment.

Whether the current attempt proceeds or stops, request the stimulation chart: starting doses, follicles observed at each scan, drug changes, relevant hormones and the clinical reasoning. A future protocol might differ, or the same approach might remain reasonable. Your age, AMH, antral follicle count and previous response all matter, yet no single result determines what the next cycle will achieve. A second opinion is valuable when the explanation remains unclear, not because changing clinics automatically improves outcomes.

• Which objective originally made IVF preferable to IUI?
• Are my tubes and sperm findings compatible with IUI?
• What happens to the medication plan and my financial quote?
• Who will confirm trigger timing and provide urgent advice?
• What should we learn from this cycle for the next one?